TODAY2 Phase 2 Follow-up

Completed

Conditions studied: Type 2 Diabetes

In brief

The primary objective of T2P2 is to track the progression of T2D and related comorbidities and complications in the TODAY cohort as they transition to young adulthood. We hypothesize that: * Youth-onset type 2 diabetes (T2D) will progress rapidly and result in high rates of diabetes-related medical complications and comorbidities. * The rapid rate of progression is related to increased insulin resistance characteristic of puberty, worse β-cell function, degree of glycemic control, control of non-glycemic factors, and obesity itself.

Key facts

Study ID
NCT02310724
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People needed
517
Starts
2014-03-01
Expected to finish
2020-01-17
Last updated by the study team
2021-08-05

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.